Repligen | RGEN - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Agilent USD 7.12B 214M 2026-03
Align Technology USD 4.23B 83.03M 2026-06
Bio Techne USD 2.09B 74.32M 2026-03
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Bruker USD 2.44B 67M 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Henry Schein USD 3.16B 109M 2026-06
Illumina USD 2.84B 162M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
OraSure Technologies USD 317.78M 4.45M 2026-06
Pacific Biosciences Of California USD -33.21M 35.58M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 15.29B 12.73B 2026-03
West Pharmaceutical Services USD 2.99B 200K 2026-06